Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction

American Journal of Cardiology

Volumn 84, Issue 5, 1999, Pages 578-582

  Kono, Tatsuji ^c   Nishina, Takuya ^b   Morita, Hiroshi ^b   Hirota, Yuzo ^a   Kawamura, Keishiro ^a   Fujiwara, Akira ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b National Hospital Organization   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; TROPONIN T;

ADULT; AGED; ARTICLE; BRAIN DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORADRENALIN BLOOD LEVEL; ORGAN DONOR; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; TECHNIQUE;

ADOLESCENT; ADULT; AGED; BRAIN DEATH; CARDIOTONIC AGENTS; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; GRAFT SURVIVAL; HEART ARREST; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; TROPONIN T;

EID: 0032818809     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00382-3     Document Type: Article

References (20)

1. Novitzky D., Wicomb W.N., Cooper D.K.C., Rose A.G., Fraser R.C., Barnard C.N. Electrocardiographic, hemodynamic and endocrine changes occurring during experimental brain death in the Chacma baboon. J Heart Transplant. 4:1984;63-69.
2. Novitzky D., Rose A.G., Cooper D.K.C. Injury of myocardial conduction tissue and coronary artery smooth muscle following brain death in the baboon. Transplantation. 45:1988;964-966.
3. Galinanes M., Hearse D.J. Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res. 71:1992;1213-1219.
4. Gilbert E.M., Krueger S.K., Murray J.L., Renlund D.G., O'Connell J.B., Gay W.A., Bristow M.R. Echocardiographic evaluation of potential cardiac transplant donors. J Thorac Cardiovasc Surg. 95:1988;1003-1007.
5. Darracott-Cankovic S., Stovin P.G.I., Wheeldon D., Wallwork J., Wells F., English T.A.H. Effect of donor heart damage on survival after transplantation. Eur J Cardiothorac Surg. 3:1989;525-532.
6. Young J.B., Naftel D.C., Bourge R.C., Kirklin J.K., Clemson B.S., Porter C.B., Rodeheffer R.J., Kenzora J.L. Matching the heart donor and heart transplant recipient clues for successful expansion of the donor pool: a multivariable, multiinstitutional report . J Heart Lung Transplant. 13:1994;353-365.
7. Novitzky D., Cooper D.K.C., Morrell D., Isaacs S. Changes from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation. 45:1988;32-36.
8. Seiler C., Laske A., Gallino A., Turina M., Jenni R. Echocardiographic evaluation of left ventricular wall motion before and after heart transplantation. J Heart Lung Transplant. 11:1992;867-874.
9. Kofke W.A., Darby J.M. Evaluation and certification of brain death. Grande C.M. Textbook of Trauma and Anesthesia and Critical Care. 1993;994-1006 Mosby Year Book, St Louis, MO.
10. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
11. Goarin J.P., Cohen S., Jacquens Y., Le Bret F., Clergue F., Viars P. Left ventricular function in brain dead donors assessment using transesophageal echocardiography . (abstr) Anesthesiology. 73:1990;A84.
12. Riou B., Dreux S., Roche S., Arthaud M., Goarin J.P., Leger P., Saada M., Viars P. Circulating cardiac troponin T in potential heart transplant donors. Circulation. 92:1995;409-414.
13. Anderson J.R., Hossein-Nia M., Brown P., Holt D.W., Murday A. Donor cardiac troponin-T predicts subsequent inotrope requirements following cardiac transplantation. Transplantation. 58:1994;1056-1057.
14. Barilla F., Gheorghiade K.P., Alam M., Khaja F., Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J. 122:1991;1522-1531.
15. Pierard L.A., de Landsheere C.M., Berthe C., Rigo P., Kulbertus H.E. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy comparison with positron emission tomography . J Am Coll Cardiol. 15:1990;1021-1031.
16. Pilati C.F., Bosso F.J., Maron M.B. Factors involved in left ventricular dysfunction after massive sympathetic activation. Am J Physiol. 263:1992;H784-H791.
17. Mertes P.M., Carteaux J.P., Jaboin Y., Pinelli G., El Abassi K., Dopff C., Atkinson J., Villemot J.P., Burlet C., Boulange M. Estimation of myocardial interstitial norepinephrine release after brain death using cardiac microdialysis. Transplantation. 57:1994;371-377.
18. Meyers C.H., D'Amico T.A., Peterseim D.S., Jayawant A.M., Steenbergen C., Sabiston D.C., Van Trigt P. Effects of triiodothyronine and vasopressin on cardiac function and myocardial blood flow after brain death. J Heart Lung Transplant. 12:1993;68-80.
19. Bristow M.R., Kantrowitz N.E., Ginsburg R., Fowler M.B. Beta-adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol. 17:1985;41-52.
20. Bittner HB, Chen EP, Milano CA, Kendall SWH, Jennings RB, Sabiston DC, Trigt PV. Myocardial beta-adrenergic receptor function and high-energy phosphates in brain death-related cardiac dysfunction. Circulation 1995;92(suppl II):II-472-II-478.